January 7, 2009: Sun Pharmaceutical Industries Ltd. announced that together with its subsidiaries, it has received final approval from USFDA for several Abbreviated New Drug Applications. Approval was received for generic hydocodone bitartate with acetaminophen (APAP) tablets. Approval was also received for generic Aredia, pamidronate disodium for injection USP, generic Lopid, gemfibrozil tablets, USP, and generic Phenargan, promethazine hydrochloride tablets.
The details can be read here.
No comments:
Post a Comment